ROSEN, A TOP RANKED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIONewsfile Corp • 12/26/20
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIOPRNewsWire • 12/18/20
FBIO Shareholder Update: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021Newsfile Corp • 12/15/20
Rosen, A Globally Recognized Firm, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIONewsfile Corp • 12/13/20
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)Business Wire • 12/09/20
FBIO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021Business Wire • 12/09/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIOBusiness Wire • 12/07/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fortress Biotech, Inc. (FBIO) InvestorsBusiness Wire • 12/07/20
ROSEN, RESPECTED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Fortress Biotech, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIOPRNewsWire • 12/05/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fortress Biotech, Inc. (FBIO) InvestorsBusiness Wire • 12/04/20
Shareholder Alert: Robbins LLP Announces Fortress Biotech, Inc. (FBIO) is Being Sued for Misleading ShareholdersBusiness Wire • 12/04/20
ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Fortress Biotech, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - FBIONewsfile Corp • 12/03/20
The Law Offices of Frank R. Cruz Announces Investigation of Fortress Biotech, Inc. (FBIO) on Behalf of InvestorsBusiness Wire • 12/03/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fortress Biotech, Inc. (FBIO) on Behalf of InvestorsBusiness Wire • 12/03/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 12/03/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fortress Biotech, Inc. (FBIO) on Behalf of InvestorsBusiness Wire • 12/03/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 12/01/20
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Fortress Biotech, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm – FBIOBusiness Wire • 12/01/20
Pomerantz Law Firm Announces the Filing of a Class Action against Fortress Biotech, Inc. Certain Officers - FBIOPRNewsWire • 11/27/20
Fortress Biotech Ranked in Deloitte's Technology Fast 500™ for the Second Year in a RowGlobeNewsWire • 11/18/20
Fortress Bio: Shares Look Attractive At 50% Discount After Avenue's IV Tramadol RejectionSeeking Alpha • 11/11/20
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 11/09/20
Fortress Biotech Announces Oral and Poster Data Presentations at the 62nd American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/04/20
